Retatrutide

Description

Retatrutide (LY3437943)

Strength Options: 5mg
Purity: ≥98% (HPLC Verified)
Form: Lyophilized powder for reconstitution
Use: For laboratory research only

Description

Retatrutide (LY3437943) is a novel investigational peptide that acts as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is currently being studied for its profound impact on body weight reduction, insulin sensitivity, and energy expenditure in metabolic research.

Preclinical and clinical research has explored Retatrutide in:

• Obesity and metabolic syndrome models

• Blood glucose regulation and insulin response

• Appetite suppression and calorie intake reduction

• Enhancing energy balance through multiple hormonal pathways

Suggested Research Protocol (for investigational use only)

• Typical Dose Studied: 0.5–12mg once weekly

• Duration: Studied over periods of 12 to 48 weeks

• Administration: Subcutaneous (SC) injection route

Storage Guidelines

• Store lyophilized powder at -20°C

• After reconstitution, refrigerate at 2–8°C

• Avoid exposure to moisture or repeated freeze-thaw cycles

⚠️ Legal Disclaimer

This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or diagnostic use. All information is provided for scientific and educational reference. By purchasing, you agree to handle this material in compliance with all applicable laws and regulations.